
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Vav2 CRISPR/Cas9 KO Plasmid (h) | sc-401490 | 20 µg | $397.00 |
VAV2 encodes Vav2, a multidomain guanine nucleotide exchange factor (GEF) that activates Rho family GTPases such as RAC1 and CDC42 downstream of receptor tyrosine kinases and integrin signaling. Through its DH-PH catalytic core and SH2/SH3-mediated interactions, Vav2 coordinates actin cytoskeleton remodeling, membrane ruffling, and focal adhesion dynamics that support cell migration and adhesion. Vav2-dependent signaling intersects with pathways including PI3K, MAPK, and Src-family kinase networks, linking extracellular cues to transcriptional and cytoskeletal outputs. Dysregulated VAV2 activity or expression has been associated with altered invasive behavior and signaling rewiring in multiple disease-relevant contexts, making it a useful node for mechanistic studies of motility and signal transduction.
Vav2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the VAV2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the VAV2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the VAV2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Vav2 protein expression.
This CRISPR knockout system enables efficient generation of VAV2-deficient cell models for investigation of Vav2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.